daptomycin · Baxter Hlthcare Corp · NDA 213645
Dapzura Rt
Earliest generic entry, as listed
11 Mar 2041
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 11173189.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11173189 | drug product, use U-3294 · sets the listed date | 11 Mar 2041 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 213645 · 001 · RLD · discontinued | powder, intravenous | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 11 Mar 2041 |